GDM modified the associations of gestational weight gain with pregnancy outcomes: a population-based cohort study Authors: Wen Jin, Ye Huang, Yiwen Qiu, Xialidan Alifu, Haoyue Cheng, Nuo Xu, Boya Wang, Shuhui Wang, Hui Liu, Danqing Chen, Yunxian Yu Published: 2025 ABSTRACT BackgroundThe timing of gestational diabetes mellitus (GDM) screening may impact the progression of gestational weight gain (GWG). Additionally, it remains unclear whether the associations of GWG with pregnancy outcomes vary based on GDM status. Thus, this study aims to investigate the effect of GDM on the associations between GWG in different periods and pregnancy outcomes.MethodsGWG was categorized into: total, before and after the oral glucose tolerance test (OGTT). The GWG rate for different periods was calculated by dividing the total GWG by the corresponding gestational week intervals, and was further classified as inadequate GWG (IGWG), normal GWG (NGWG), or excessive GWG (EGWG). Logistic regression models were used to analyze the associations of GWG rate and GWG categories with pregnancy outcomes. To assess potential effect modification by GDM status, interaction terms were included in the models, and crossover analyses were conducted.Results2190 women with GDM and 10,817 women without GDM were included. In both groups, increasing GWG rate at each period was associated with higher risks of large for gestational age (LGA), macrosomia, and cesarean delivery, and lower risks of small for gestational age (SGA) and low birth weight (LBW). A U-shaped relationship between GWG rate and preterm birth (PTB) was observed after OGTT, but not before. The associations of total GWG rate and GWG rate after OGTT with LGA risk were stronger in women with GDM (P for interaction < 0.001). Among women without GDM, IGWG at each period significantly increased SGA and LBW risks, which was not observed in women with GDM. In both groups, EGWG during any period was significantly associated with higher risks of LGA, macrosomia, and cesarean delivery, with PTB primarily observed after OGTT. Crossover analysis indicated that women with GDM, whether with NGWG or EGWG during total pregnancy and after OGTT period, had higher LGA risk than women without GDM and with NGWG, with the highest risk in the EGWG group (P for interaction < 0.05).ConclusionAssociations of GWG with pregnancy outcomes, especially after OGTT, differed by GDM status. These findings underscore the need for individualized weight management in GDM.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12967-025-07474-3. Background Gestational diabetes mellitus (GDM), the most common medical conditions during pregnancy, is characterized as abnormal glucose tolerance with onset during pregnancy [1]. Currently, the prevalence of GDM continues to increase due to some factors, including rising prevalence of obesity and maternal age among reproductive women [1, 2]. Extensive studies have underlined the close associations between GDM and adverse perinatal outcomes, such as increased risk for large for gestational age (LGA), macrosomia, caesarean delivery, preterm birth (PTB) and cardiovascular disease, etc [3, 4]. Gestational weight gain (GWG), demonstrated as important modifiable factor for maternal and neonatal outcomes [5, 6], is generally defined as the differences between maternal weight at delivery and weight before pregnancy or at the first prenatal visit. With no global consensus on the recommendation of GWG currently, revised recommended GWG provided by The Institute of Medicine (IOM) were widely used [7]. A systematic review and meta-analysis including more than 1 million pregnant women reported nearly 50% of the population exceeded the recommended GWG [8]. Both insufficient GWG (IGWG) and excessive GWG (EGWG) were demonstrated to be associated with adverse outcomes [8]. In addition to EGWG, GDM women often showed IGWG in late pregnancy in practices, raising some concerns about the increased risk of small for gestational age (SGA) or low birth weight (LBW). However, several studies have suggested that the pattern of GWG among women with GDM differs from that of women without GDM, often characterized by lower GWG [9, 10]. This has raised concerns that IGWG in this population may increase the risk of adverse outcomes such as SGA or PTB. However, the evidence remains inconclusive, with some studies have reporting that IGWG is associated with an increased risk of SGA [11, 12] while others indicating null findings [13, 14]. Additionally, the GWG management may be required to adjust based on a universal screening for GDM (i.e., oral glucose tolerance test (OGTT) between 24 and 28 weeks). Two studies have indicated that blood glucose control or weight management after OGTT may leads to a slower rate of GWG in women with GDM during the third trimester or after OGTT [10, 15], further highlighting the importance of OGTT as a critical time point for GWG progression. However, the majority of previous studies focused on the associations of total or trimester-specific GWG with pregnancy outcomes [13, 16, 17]. While such approaches provide useful information on overall or stage-specific weight gain, they do not account for clinical events during pregnancy that may substantially alter GWG trajectories. Moreover, a study has indicated that the abnormal intrauterine metabolic environment, as seen in women with GDM, may influence the relationship between GWG and pregnancy outcomes [18]. However, most existing studies have focused on evaluating the associations between GWG and pregnancy outcomes separately in women with and without GDM, with few directly comparing the effects between the two groups. Therefore, further investigation is needed to explore the associations between GWG before and after OGTT and pregnancy outcomes, and whether these effects differ by GDM status. Thus, this study aims to investigate the associations of GWG rate and GWG categories (based on the IOM guidelines) with pregnancy outcomes, with a particular focus on the period before and after OGTT. Additionally, we further explore whether these associations differ between women with and without GDM. Hence, this study aims to provide a more comprehensive understanding of GWG management and to offer evidence-based support for optimizing GWG strategies, particularly in the context of GDM, in order to improve maternal and fetal health outcomes. Materials and methods Study design and study population This is a population-based retrospective cohort study. Participants who met the following criteria were included: (1) Women aged 18 to 50 years; (2) First antenatal visit conducted between 8 and 13 gestational weeks; (3) Singleton pregnancy; (4) Underwent OGTT after 24 weeks of gestation for the diagnosis of GDM. The exclusion criteria were as follow: (1) Stillbirth, fetal malformation, threatened abortion, or miscarriage; (2) Diagnosis of psychiatric disorders or chronic wasting diseases (e.g., malignancies, autoimmune diseases); (3) Pre-existing diabetes mellitus before pregnancy; (4) pregnancy by assisted reproductive technology; (5) Missing maternal weight data at any of the key time points during pregnancy (i.e., early pregnancy, at the time of OGTT, and at delivery); (6) Missing data on neonatal birth weight or adverse pregnancy outcomes. This study protocol was approved by the institutional review board of Zhejiang University School of Medicine. Data source The data was from a comprehensive Electronic Medical Record System (EMRS) of Zhoushan Maternal and Child Care Hospital, Zhejiang, China, spanning from 2011 to 2022. The record of information was followed the guidelines of Zhoushan Maternal and Child Care Hospital, which has been described previously [19]. Briefly, to enhance the quality of prenatal care, a Pregnancy Register is utilized during prenatal visits. Pregnant women were required to complete an initial Pregnancy Register between 8 and 13 weeks of gestation, providing demographic information, reproductive history, and basic maternal health data. Most of this information, apart from anthropometric measurements such as weight or height, was self-reported by pregnant women and verified by clinical doctors before being uploaded to the EMRS system for registration. Following registration, each woman was assigned a unique personal registration number and underwent prenatal follow-up until delivery. During antenatal care visits, ultrasound examinations, fetal growth assessments, and records of pregnancy and delivery complications were recorded and uploaded. Additionally, newborn data was recorded. Anthropometric indicators such as height, weight and blood pressure were measured by qualified staff using relevant tools at each antenatal care visit, while biochemical indicators like glucose levels were obtained through laboratory testing. The definition of GDM Women would be received a routine screening for GDM with a 75-g OGTT at 24–28 weeks in China [20]. The International Association for Diabetes in Pregnancy Study Groups (IADPSG) criteria was used to diagnose GDM, with cut-off points of 5.1 mmol/L for fasting glucose, 10.0 mmol/L for 1-hour post glucose or 8.5 mmol/L for 2-hour post glucose [21]. The definition of GWG Gestational weight was routinely measured by qualified staff in each antenatal examination. Pre-pregnant BMI was calculated using weight and height at the first antenatal care visit. Total GWG for the mid and late trimesters was calculated by subtracting the weight at the first trimester (8–13 weeks) from the weight at delivery. To account for differences in gestational age among individuals, the total GWG rate (kg/week) was calculated by dividing the total GWG by the difference in gestational weeks between delivery and thirteen weeks.\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\begin{aligned}\:\text{Total}\,\text{GWG}\,\text{(kg)} \qquad\qquad\qquad\qquad\qquad\cr=\text{GWG}_\text{delivery} -\text{GWG}_\text{1st trimester}\end{aligned}$$\end{document}\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\eqalign{ {\rm{Total}}\, {\rm{GWG}}\,{\rm{rate}}\,{\rm{(kg/week)}} \qquad\qquad\cr = {{{\rm{GW}}{{\rm{G}}_{{\rm{delivery}}}} - {\rm{GW}}{{\rm{G}}_{{\rm{1st}}\,{\rm{trimester}}}}} \over {{\rm{Wee}}{{\rm{k}}_{{\rm{delivery}}}} - 13}} \cr}$$\end{document} Subsequently, GWG was then categorized into periods before and after OGTT based on the timing of the OGTT. GWG before OGTT was calculated as maternal weight at OGTT minus maternal weight at the first trimester, while GWG after OGTT was calculated as the maternal weight at delivery minus maternal weight at OGTT. Considering the variations in the timing of OGTT among individuals, GWG rate before and after OGTT was calculated, respectively. GWG rate before OGTT was determined by dividing GWG before OGTT by the difference in gestational weeks between OGTT and thirteen weeks. Similarly, GWG rates after OGTT was calculated by dividing GWG after OGTT by the difference in gestational weeks between delivery and OGTT. Lastly, total GWG, GWG before and after OGTT were categorized as three categories (i.e., IGWG, normal GWG (NGWG) and EGWG), respectively, according to the IOM guideline for GWG rates in the second and third trimesters [7]. Women were first classified according to pre-pregnancy BMI: underweight (< 18.5 kg/m²), normal weight (18.5–24.9 kg/m²), overweight (25–29.9 kg/m²), and obesity (≥ 30 kg/m²). Within each BMI category, GWG categories were defined using the IOM weekly gain recommendations (0.44–0.58 kg/week for underweight, 0.35–0.50 kg/week for normal weight, 0.23–0.33 kg/week for overweight, and 0.17–0.27 kg/week for obesity). The definition of outcomes SGA, appropriate for gestational age (AGA) and LGA were defined as infant birth weight below 10th percentile, between the 10th and 90th percentile, and above the 90th percentile of gestational age and sex-specific birth weights, respectively, according to the Growth standard for Chinese newborns by gestational age [22]. LBW, normal birth weight (NBW) and macrosomia were defined as infant birth weight less than 2500 g, between 2500 and 4000 g, and equal to or greater than 4000 g, respectively. PTB was defined as gestational weeks at delivery less than 37 weeks. Information of birth by caesarean delivery was collected from EMRS at delivery. Covariates The covariates were drawn from EMRS directly. The continuous covariates included maternal age at delivery (years), maternal pre-pregnancy BMI (kg/m2), gestational weeks at delivery (weeks), parity (number of previous births). The categorized covariates included maternal educational status (junior high school or less, senior high school, college or higher and unknown), smoking status of pre-pregnancy (Yes or No), drinking status of pre-pregnancy (Yes or No), offspring sex (male or female). Missing data of covariate variables (< 5%) were filled in by multiple imputation model (R, package mice). Statistical analysis All variables were presented as mean ± standard deviation (SD) for continuous variables and numbers with percentage for categorical variables. To compare differences of the maternal and neonatal variables between women with and without GDM, t-test and Chi-square test were conducted for continuous and categorical variables, respectively. Multivariable-adjusted restricted cubic spline (RCS) models were first employed to explore potential nonlinear associations of GWG rate in different periods with various pregnancy outcomes. Subsequently, multivariable-adjusted binary logistic regression models were used to evaluate associations between GWG rates and GWG categories with the risks of PTB and cesarean delivery. Meanwhile, multivariable-adjusted logistic regression analyses were conducted to assess associations with SGA, LGA, LBW, and macrosomia. When the RCS models suggested potential inflection points in the associations between GWG rates and pregnancy outcomes, supplementary piecewise regression analyses were performed based on the identified thresholds. Furthermore, to examine potential effect modification by GDM, stratified analyses were conducted according to GDM status, and interaction terms were tested using likelihood ratio tests. Additionally, crossover analyses combining GDM status and GWG categories were performed. To further explore the potential influence of maternal hemodynamics, we made additional adjustments for mean arterial pressure (MAP) of late trimester in sensitivity analysis. MAP was defined as diastolic blood pressure (DBP) + 1/3 (systolic blood pressure [SBP] – DBP) and calculated at each prenatal clinic visit from routinely collected blood pressure measurements. These models were adjusted for the covariates mentioned above. In addition, GWG before and after OGTT were mutually adjusted in models evaluating their respective associations with pregnancy outcomes. Odds ratio (OR), adjusted odds ratio (aOR) and 95% confidence intervals (CI) were reported for corresponding models. Data were analyzed with R software (4.4.0). Two-sided P-value < 0.05 was considered statistically significant. Result Basic characteristics A total of 17,735 mother-child pairs were included initially, while 13,007 mother-child pairs were finally included in our analysis after excluding women diagnosed as pre-pregnancy diabetes, women of miscarriage or post-term pregnancy and pregnancy by assisted reproductive technology (n = 1794); women with missing data of maternal weight for calculating GWG (n = 2688); and women with extreme or abnormal GWG data (n = 246). The extreme or abnormal GWG was defined as values exceeding 5 standard deviations or falling outside the normal range. Among the included 13,007 singleton women, mean maternal age was 29.16 years (SD = 4.16), mean BMI was 21.08 (SD = 3.08), mean gestation weeks at the first antenatal visit was 12.45 weeks (SD = 2.34) and mean gestation weeks at OGTT was 25.29 weeks (SD = 1.23). Table 1 presents a summary of the characteristics categorized by women with GDM (n = 2190) and women without GDM (n = 10,817). Women with GDM were older and had higher BMI, gravidity, and proportion of multipara. Table 1Basic characteristics of pregnant women stratified by GDM statusCharacteristicsAll ParticipantsWomen without GDMWomen with GDM P N13,00710,8172190 Maternal characteristics Age (years), mean ± SD29.16 (4.16)28.84 (4.05)30.71 (4.33) < 0.001 Pre-pregnancy BMI, mean ± SD21.08 (3.08)20.91 (2.97)21.92 (3.46) < 0.001 Gestation age at the first antenatal visit (weeks), mean ± SD12.45 (2.34)12.48 (2.39)12.33 (2.05) 0.003 Gestational age at OGTT (weeks), mean ± SD25.29 (1.23)25.27 (1.21)25.40 (1.31) < 0.001 Maternal educational level, n (%) < 0.001 Junio high school or less2160 (16.6)1771 (16.4)389 (17.8) Senior high school1427 (11.0)1147 (10.6)280 (12.8) College or higher5212 (40.1)4325 (40.0)887 (40.5) Not known4208 (32.4)3574 (33.0)634 (28.9)Parity, n (%) < 0.001 Primipara8314 (63.9)7045 (65.1)1269 (57.9) Multipara4693 (36.1)3772 (34.9)921 (42.1)Gravidity, mean ± SD2.09 (1.27)2.06 (1.23)2.26 (1.43) < 0.001 Smoking status of pre-pregnancy, n (%)0.795 No12,903 (99.2)10,732 (99.2)2171 (99.1) Yes104 (0.8)85 (0.8)19 (0.9)Drinking status of pre-pregnancy, n (%)0.217 No12,878 (99.0)10,704 (99.0)2174 (99.3) Yes129 (1.0)113 (1.0)16 (0.7)Delivery mode, n (%) < 0.001 Natural birth8174 (62.8)6928 (64.0)1246 (56.9) Cesarean section4833 (37.2)3889 (36.0)944 (43.1) Offspring characteristics Gestational age at delivery (weeks), mean ± SD39.48 (1.39)39.52 (1.38)39.27 (1.41) < 0.001 Gender, n (%)0.171 Male6749 (51.9)5583 (51.6)1166 (53.2) Female6258 (48.1)5234 (48.4)1024 (46.8)Birth weight (g), mean ± SD,3304.06 (434.43)3302.57 (428.22)3311.40 (463.92)0.386Birth weight categories, n (%) < 0.001 SGA1044 (8.0)880 (8.1)164 (7.5) Normal10,121 (77.8)8553 (79.1)1568 (71.6) LGA1842 (14.2)1384 (12.8)458 (20.9)Birth weight categories, n (%) 0.022 LBW358 (2.8)295 (2.7)63 (2.9) Normal12,015 (92.4)10,034 (92.8)1981 (90.5) Macrosomia634 (4.9)488 (4.5)146 (6.7)Premature birth, n (%) 0.002 No12,510 (96.2)10,430 (96.4)2080 (95.0) Yes497 (3.8)387 (3.6)110 (5.0)Abbreviations: BMI, Body mass index; GDM, Gestational diabetes mellitus; LGA, Large for gestational age infant; LBW, Low birth weight; OGTT, Oral glucose tolerance test; SD, standard deviation; SGA, Small for gestational age Table 1Basic characteristics of pregnant women stratified by GDM statusCharacteristicsAll ParticipantsWomen without GDMWomen with GDM P N13,00710,8172190 Maternal characteristics Age (years), mean ± SD29.16 (4.16)28.84 (4.05)30.71 (4.33) < 0.001 Pre-pregnancy BMI, mean ± SD21.08 (3.08)20.91 (2.97)21.92 (3.46) < 0.001 Gestation age at the first antenatal visit (weeks), mean ± SD12.45 (2.34)12.48 (2.39)12.33 (2.05) 0.003 Gestational age at OGTT (weeks), mean ± SD25.29 (1.23)25.27 (1.21)25.40 (1.31) < 0.001 Maternal educational level, n (%) < 0.001 Junio high school or less2160 (16.6)1771 (16.4)389 (17.8) Senior high school1427 (11.0)1147 (10.6)280 (12.8) College or higher5212 (40.1)4325 (40.0)887 (40.5) Not known4208 (32.4)3574 (33.0)634 (28.9)Parity, n (%) < 0.001 Primipara8314 (63.9)7045 (65.1)1269 (57.9) Multipara4693 (36.1)3772 (34.9)921 (42.1)Gravidity, mean ± SD2.09 (1.27)2.06 (1.23)2.26 (1.43) < 0.001 Smoking status of pre-pregnancy, n (%)0.795 No12,903 (99.2)10,732 (99.2)2171 (99.1) Yes104 (0.8)85 (0.8)19 (0.9)Drinking status of pre-pregnancy, n (%)0.217 No12,878 (99.0)10,704 (99.0)2174 (99.3) Yes129 (1.0)113 (1.0)16 (0.7)Delivery mode, n (%) < 0.001 Natural birth8174 (62.8)6928 (64.0)1246 (56.9) Cesarean section4833 (37.2)3889 (36.0)944 (43.1) Offspring characteristics Gestational age at delivery (weeks), mean ± SD39.48 (1.39)39.52 (1.38)39.27 (1.41) < 0.001 Gender, n (%)0.171 Male6749 (51.9)5583 (51.6)1166 (53.2) Female6258 (48.1)5234 (48.4)1024 (46.8)Birth weight (g), mean ± SD,3304.06 (434.43)3302.57 (428.22)3311.40 (463.92)0.386Birth weight categories, n (%) < 0.001 SGA1044 (8.0)880 (8.1)164 (7.5) Normal10,121 (77.8)8553 (79.1)1568 (71.6) LGA1842 (14.2)1384 (12.8)458 (20.9)Birth weight categories, n (%) 0.022 LBW358 (2.8)295 (2.7)63 (2.9) Normal12,015 (92.4)10,034 (92.8)1981 (90.5) Macrosomia634 (4.9)488 (4.5)146 (6.7)Premature birth, n (%) 0.002 No12,510 (96.2)10,430 (96.4)2080 (95.0) Yes497 (3.8)387 (3.6)110 (5.0)Abbreviations: BMI, Body mass index; GDM, Gestational diabetes mellitus; LGA, Large for gestational age infant; LBW, Low birth weight; OGTT, Oral glucose tolerance test; SD, standard deviation; SGA, Small for gestational age Basic characteristics of pregnant women stratified by GDM status Abbreviations: BMI, Body mass index; GDM, Gestational diabetes mellitus; LGA, Large for gestational age infant; LBW, Low birth weight; OGTT, Oral glucose tolerance test; SD, standard deviation; SGA, Small for gestational age GWG in women with and without GDM Table 2 presents the distributions of GWG rates across different periods, comparing women with and without GDM. Overall, women with GDM showed significantly lower GWG rates before OGTT (0.46 ± 0.21 kg/week vs. 0.49 ± 0.20 kg/week), and after OGTT (0.37 ± 0.19 kg/week vs. 0.52 ± 0.18 kg/week), compared to women without GDM (all P < 0.001). Among women without GDM, the GWG rate after OGTT was higher than that before OGTT (0.52 ± 0.18 kg/week vs. 0.49 ± 0.20 kg/week, P < 0.001), whereas the opposite trend was observed in women with GDM (0.37 ± 0.19 kg/week vs. 0.46 ± 0.21 kg/week, P < 0.001). Table 2Gestational weight gain of pregnant women stratified by GDM statusCharacteristicsAllNon-GDMGDM P N13,00710,8172190 Mid and late trimester GWG (kg), mean ± SD12.54 (3.79)12.95 (3.66)10.52 (3.80)< 0.001GWG rate (kg/week), mean ± SD0.49 (0.15)0.50 (0.14)0.41 (0.15)< 0.001GWG categories, n (%)< 0.001 IGWG2189 (16.8)1517 (14.0)672 (30.7) NGWG4762 (36.6)3956 (36.6)806 (36.8) EGWG6056 (46.6)5344 (49.4)712 (32.5) Before OGTT GWG (kg), mean ± SD5.84 (2.46)5.90 (2.44)5.56 (2.56)< 0.001GWG rate (kg/week), mean ± SD0.48 (0.20)0.49 (0.20)0.46 (0.21)< 0.001GWG categories, n (%)0.004 IGWG3121 (24.0)2541 (23.5)580 (26.5) NGWG3932 (30.2)3266 (30.2)666 (30.4) EGWG5954 (45.8)5010 (46.3)944 (43.1) After OGTT GWG (kg), mean ± SD6.59 (2.62)6.94 (2.49)4.85 (2.58)< 0.001GWG rate (kg/week), mean ± SD0.50 (0.19)0.52 (0.18)0.37 (0.19)< 0.001GWG categories, n (%)< 0.001 IGWG2831 (21.8)1888 (17.5)943 (43.1) NGWG3875 (29.8)3258 (30.1)617 (28.2) EGWG6301 (48.4)5671 (52.4)630 (28.8)Abbreviations: EGWG, Excessive gestational weight gain; GDM, Gestational diabetes mellitus; GWG, Gestational weight gain; IGWG, Insufficient gestational weight gain; NGWG, Normal gestational weight gain; OGTT, Oral glucose tolerance test Table 2Gestational weight gain of pregnant women stratified by GDM statusCharacteristicsAllNon-GDMGDM P N13,00710,8172190 Mid and late trimester GWG (kg), mean ± SD12.54 (3.79)12.95 (3.66)10.52 (3.80)< 0.001GWG rate (kg/week), mean ± SD0.49 (0.15)0.50 (0.14)0.41 (0.15)< 0.001GWG categories, n (%)< 0.001 IGWG2189 (16.8)1517 (14.0)672 (30.7) NGWG4762 (36.6)3956 (36.6)806 (36.8) EGWG6056 (46.6)5344 (49.4)712 (32.5) Before OGTT GWG (kg), mean ± SD5.84 (2.46)5.90 (2.44)5.56 (2.56)< 0.001GWG rate (kg/week), mean ± SD0.48 (0.20)0.49 (0.20)0.46 (0.21)< 0.001GWG categories, n (%)0.004 IGWG3121 (24.0)2541 (23.5)580 (26.5) NGWG3932 (30.2)3266 (30.2)666 (30.4) EGWG5954 (45.8)5010 (46.3)944 (43.1) After OGTT GWG (kg), mean ± SD6.59 (2.62)6.94 (2.49)4.85 (2.58)< 0.001GWG rate (kg/week), mean ± SD0.50 (0.19)0.52 (0.18)0.37 (0.19)< 0.001GWG categories, n (%)< 0.001 IGWG2831 (21.8)1888 (17.5)943 (43.1) NGWG3875 (29.8)3258 (30.1)617 (28.2) EGWG6301 (48.4)5671 (52.4)630 (28.8)Abbreviations: EGWG, Excessive gestational weight gain; GDM, Gestational diabetes mellitus; GWG, Gestational weight gain; IGWG, Insufficient gestational weight gain; NGWG, Normal gestational weight gain; OGTT, Oral glucose tolerance test Gestational weight gain of pregnant women stratified by GDM status Abbreviations: EGWG, Excessive gestational weight gain; GDM, Gestational diabetes mellitus; GWG, Gestational weight gain; IGWG, Insufficient gestational weight gain; NGWG, Normal gestational weight gain; OGTT, Oral glucose tolerance test Table 2 presents the distribution of GWG categories of different periods. Before OGTT, 23.5% of women without GDM had IGWG, 30.2% had NGWG, and 46.3% had EGWG. After OGTT, the proportions shifted to 17.5% for IGWG, 30.1% for NGWG, and 52.4% for EGWG. Among women with GDM, 26.5% had IGWG, 30.4% had NGWG, and 43.1% had EGWG before OGTT. After OGTT, the distribution changed markedly, with 43.1% having IGWG, 28.2% having NGWG, and 28.8% having EGWG. The associations of GWG rates with pregnancy outcomes in women with and without GDM Additional file 1: Figure S1 displays the relationships between GWG rates in different periods and pregnancy outcomes, along with their nonlinear trend test results. RCS analysis revealed that in both women without GDM and women with GDM, no significant inflection points were observed between GWG rates during various periods and pregnancy outcomes except for PTB. Specifically, the total GWG rate and GWG rate after OGTT in both groups showed significant nonlinear associations with PTB risk (P for nonlinearity < 0.05), demonstrating a U-shaped curve with an inflection point at 0.44 kg/week. In contrast, the GWG rate before OGTT was linearly associated with PTB risk (P for nonlinearity > 0.05). Multivariable logistic regression analyses revealed significant associations between GWG rates and pregnancy outcomes (Table 3). Regarding birth weight-related outcomes, each 0.1 kg/week increase in total GWG rate was associated with a 27% lower risk of SGA, a 42% higher risk of LGA, a 48% higher risk of macrosomia, and an 18% lower risk of LBW in women without GDM. In contrast, among women with GDM, the same GWG increase was associated with a 14% reduction in SGA risk, a 66% increase in LGA risk, and a 58% increase in macrosomia risk, but showed no significant association with LBW. Analysis of GWG rates before and after OGTT showed largely consistent with those observed for total GWG rate. However, the GWG rate after OGTT was not significantly associated with LBW risk in either group. Additionally, in women with GDM, GWG rates during any period were not significantly associated with SGA risk. Notably, for LGA risk, the effect of GWG rate after OGTT in women with GDM (aOR = 1.30, 95% CI: 1.23, 1.38) was stronger than that of GWG rate before OGTT (aOR = 1.26, 95% CI: 1.19, 1.33), whereas the opposite trend was observed in women without GDM (aOR before OGTT =1.26, 95% CI: 1.22, 1.30; aOR after OGTT =1.11, 95% CI: 1.07, 1.15). Similar patterns were found for macrosomia. Table 3Associations between GWG rate and adverse pregnancy outcomesOutcomesGWG rate#aOR (95%CI)P for interaction $Women without GDMWomen with GDMSGA aMid and late trimester0.73 (0.69, 0.77)0.86 (0.76, 0.98) 0.016 Before OGTT c0.79 (0.75, 0.82)0.85 (0.78, 0.93)0.058After OGTT d0.96 (0.92, 1.00)1.00 (0.91, 1.09)0.412LGA aMid and late trimester1.42 (1.36, 1.48)1.66 (1.53, 1.81) 0.032 Before OGTT c1.26 (1.22, 1.30)1.26 (1.19, 1.33)0.452After OGTT d1.11 (1.07, 1.15)1.30 (1.23, 1.38) < 0.001 LBW bMid and late trimester0.82 (0.74, 0.90)0.81 (0.64, 1.02)0.871Before OGTT0.79 (0.73, 0.86)0.77 (0.64, 0.92)0.751After OGTT1.04 (0.96, 1.12)1.07 (0.91, 1.26)0.836Macrosomia bMid and late trimester1.48 (1.38, 1.57)1.58 (1.40, 1.79)0.951Before OGTT c1.25 (1.20, 1.31)1.27 (1.16, 1.38)0.510After OGTT d1.16 (1.10, 1.22)1.24 (1.13, 1.36)0.284PTB aMid and late trimester1.07 (0.99, 1.15)1.08 (0.94, 1.23)0.776Rate ≤ 0.44 kg/week0.76 (0.60, 0.95)0.87 (0.65, 1.14)0.648Rate > 0.44 kg/week1.11 (0.98, 1.25)1.55 (1.16, 2.06) 0.027 Before OGTT c0.99 (0.94, 1.05)1.02 (0.92, 1.12)0.715After OGTT d1.12 (1.06, 1.19)1.04 (0.94, 1.15)0.273Rate ≤ 0.44 kg/week0.80 (0.67, 0.95)0.80 (0.67, 0.96)0.904Rate > 0.44 kg/week1.24 (1.14, 1.35)1.34 (1.07, 1.67)0.549Cesarean delivery bMid and late trimester1.17 (1.13, 1.20)1.11 (1.04, 1.18)0.057Before OGTT c1.06 (1.04, 1.08)1.04 (0.99, 1.09)0.182After OGTT d1.10 (1.07, 1.13)1.07 (1.02, 1.12)0.113Abbreviations: aOR, adjusted odds ratio; CI: confidence intervals; GDM, gestational diabetes mellitus; GWG, gestational weight gain; IGWG, insufficient gestational weight gain; LGA, large for gestational age; LBW, low birth weight; NGWG, normal gestational weight gain; SGA, small for gestational age; PTB: premature birth;a: adjusted for maternal age, infant gender, parity, smoking status, drinking status, maternal education, pre-pregnancy body mass index;b: adjusted for maternal age, infant gender, parity, smoking status, drinking status, maternal education, pre-pregnancy body mass index, gestational weeks at delivery;c: additionally adjusted in all models plus GWG before OGTT;d: additionally adjusted in all models plus GWG after OGTT;#: In the regression analysis, the GWG rate was analyzed per 0.1 kg/week increment Table 3Associations between GWG rate and adverse pregnancy outcomesOutcomesGWG rate#aOR (95%CI)P for interaction $Women without GDMWomen with GDMSGA aMid and late trimester0.73 (0.69, 0.77)0.86 (0.76, 0.98) 0.016 Before OGTT c0.79 (0.75, 0.82)0.85 (0.78, 0.93)0.058After OGTT d0.96 (0.92, 1.00)1.00 (0.91, 1.09)0.412LGA aMid and late trimester1.42 (1.36, 1.48)1.66 (1.53, 1.81) 0.032 Before OGTT c1.26 (1.22, 1.30)1.26 (1.19, 1.33)0.452After OGTT d1.11 (1.07, 1.15)1.30 (1.23, 1.38) < 0.001 LBW bMid and late trimester0.82 (0.74, 0.90)0.81 (0.64, 1.02)0.871Before OGTT0.79 (0.73, 0.86)0.77 (0.64, 0.92)0.751After OGTT1.04 (0.96, 1.12)1.07 (0.91, 1.26)0.836Macrosomia bMid and late trimester1.48 (1.38, 1.57)1.58 (1.40, 1.79)0.951Before OGTT c1.25 (1.20, 1.31)1.27 (1.16, 1.38)0.510After OGTT d1.16 (1.10, 1.22)1.24 (1.13, 1.36)0.284PTB aMid and late trimester1.07 (0.99, 1.15)1.08 (0.94, 1.23)0.776Rate ≤ 0.44 kg/week0.76 (0.60, 0.95)0.87 (0.65, 1.14)0.648Rate > 0.44 kg/week1.11 (0.98, 1.25)1.55 (1.16, 2.06) 0.027 Before OGTT c0.99 (0.94, 1.05)1.02 (0.92, 1.12)0.715After OGTT d1.12 (1.06, 1.19)1.04 (0.94, 1.15)0.273Rate ≤ 0.44 kg/week0.80 (0.67, 0.95)0.80 (0.67, 0.96)0.904Rate > 0.44 kg/week1.24 (1.14, 1.35)1.34 (1.07, 1.67)0.549Cesarean delivery bMid and late trimester1.17 (1.13, 1.20)1.11 (1.04, 1.18)0.057Before OGTT c1.06 (1.04, 1.08)1.04 (0.99, 1.09)0.182After OGTT d1.10 (1.07, 1.13)1.07 (1.02, 1.12)0.113Abbreviations: aOR, adjusted odds ratio; CI: confidence intervals; GDM, gestational diabetes mellitus; GWG, gestational weight gain; IGWG, insufficient gestational weight gain; LGA, large for gestational age; LBW, low birth weight; NGWG, normal gestational weight gain; SGA, small for gestational age; PTB: premature birth;a: adjusted for maternal age, infant gender, parity, smoking status, drinking status, maternal education, pre-pregnancy body mass index;b: adjusted for maternal age, infant gender, parity, smoking status, drinking status, maternal education, pre-pregnancy body mass index, gestational weeks at delivery;c: additionally adjusted in all models plus GWG before OGTT;d: additionally adjusted in all models plus GWG after OGTT;#: In the regression analysis, the GWG rate was analyzed per 0.1 kg/week increment Associations between GWG rate and adverse pregnancy outcomes Abbreviations: aOR, adjusted odds ratio; CI: confidence intervals; GDM, gestational diabetes mellitus; GWG, gestational weight gain; IGWG, insufficient gestational weight gain; LGA, large for gestational age; LBW, low birth weight; NGWG, normal gestational weight gain; SGA, small for gestational age; PTB: premature birth; a: adjusted for maternal age, infant gender, parity, smoking status, drinking status, maternal education, pre-pregnancy body mass index; b: adjusted for maternal age, infant gender, parity, smoking status, drinking status, maternal education, pre-pregnancy body mass index, gestational weeks at delivery; c: additionally adjusted in all models plus GWG before OGTT; d: additionally adjusted in all models plus GWG after OGTT; #: In the regression analysis, the GWG rate was analyzed per 0.1 kg/week increment For PTB, when the total GWG rate was ≤ 0.44 kg/week, each 0.1 kg/week increase was associated with a significantly reduced risk of PTB in women without GDM (aOR = 0.76, 95% CI: 0.60, 0.95), whereas when the GWG rate > 0.44 kg/week, it was associated with increased PTB risk in women with GDM (aOR = 1.55, 95% CI: 1.16, 2.06). The GWG rate before OGTT was not significantly associated with PTB in either group, while the GWG rate after OGTT was significantly associated with increased PTB risk in both women with GDM (aOR = 1.34, 95% CI: 1.07, 1.67) and without GDM (aOR = 1.24, 95% CI: 1.14, 1.35). Regarding cesarean delivery, higher total and after-OGTT GWG rates were significantly associated with increased risk in both groups. The GWG rate before OGTT was only associated with cesarean delivery risk in women without GDM (aOR = 1.06, 95% CI: 1.04, 1.08). Further interaction analysis revealed the following (Table 3): for SGA, a significant interaction was found between total GWG rate and GDM status (P for interaction = 0.016). For LGA, significant interactions were observed for both total and post-OGTT GWG rates (P for interaction = 0.032 and < 0.001, respectively). For PTB, a significant interaction was detected between total GWG rate and GDM status when the GWG rate exceeded 0.44 kg/week (P for interaction = 0.027). No significant interactions were found between GWG rates and GDM status for LBW, macrosomia, or cesarean delivery (P for interaction > 0.05). The associations of GWG categories with pregnancy outcomes in women with and without GDM Additional file 1: Table S1 presents the associations between GWG categories and pregnancy outcomes across different periods. Among women without GDM, compared to NGWG, total IGWG was significantly associated with increased risks of SGA (aOR = 1.85, 95% CI: 1.55, 2.22) and LBW (aOR = 2.14, 95% CI: 1.43, 3.20). In contrast, among women with GDM, similar results were not observed. Total EGWG was associated with elevated risks of LGA (aOR without GDM=1.90, 95% CI: 1.66, 2.17; aOR with GDM=2.13, 95% CI: 1.66, 2.72), macrosomia (aOR = 2.27 without GDM, 95% CI: 1.83, 2.83; aOR with GDM=2.47, 95% CI: 1.65, 3.68), and cesarean delivery (aOR without GDM=1.22, 95% CI: 1.12, 1.34; aOR with GDM=1.35, 95% CI: 1.08, 1.68). Similar associations were observed when evaluating GWG before OGTT with pregnancy outcomes in both groups. However, after OGTT, the association of IGWG with developing LBW were no longer observed in women without GDM; EGWG after OGTT were found to be associated with PTB (aOR without GDM = 1.35; 95% CI: 1.06, 1.73; aOR with GDM = 2.25; 95% CI: 1.28, 3.96) in both groups. Similar trends were observed during both the before and after OGTT periods. However, before OGTT, women with GDM and NGWG were not significantly associated with macrosomia, and those with EGWG were not associated with PTB, which differed from the findings in the mid-to-late trimester analysis. In contrast, after OGTT, women with GDM and IGWG showed a significantly increased risk of PTB (aOR = 1.52, 95% CI: 1.07, 2.17), while those with EGWG were not significantly associated with cesarean delivery. To further examine potential differences in these associations by GDM status, we conducted a crossover analysis of GWG categories and GDM status across different periods. As shown in Additional file 1: Table S2 and Fig. 1, using women without GDM and with NGWG as the reference, women with GDM and total IGWG showed no significant associations with pregnancy outcomes. Women with GDM and NGWG had significantly increased risks of LGA (aOR = 1.89, 95% CI: 1.53, 2.34) and macrosomia (aOR = 1.61, 95% CI: 1.11, 2.33). EGWG in women with GDM was associated with markedly increased risks of LGA (aOR = 4.03, 95% CI: 3.31, 4.90), macrosomia (aOR = 4.24, 95% CI: 3.13, 5.76), PTB (aOR = 1.65, 95% CI: 1.14, 2.39), and cesarean delivery (aOR = 1.33, 95% CI: 1.12, 1.58). Interaction analyses revealed statistically significant interactions between GWG categories and GDM status for both SGA (P for interaction = 0.044) and LGA (P for interaction = 0.036) in the mid-late trimester. Further interaction analysis also revealed a significant interaction between GWG categories and GDM status after OGTT for the risk of LGA (P for interaction < 0.001), whereas no significant interaction was observed before OGTT. Fig. 1Associations of GWG categories with adverse pregnancy outcomes among women with GDM compared to women without GDM. a: Associations of GWG categories at mid-late trimester with adverse pregnancy outcomes among women with GDM compared to women without GDM; b: Associations of GWG categories before OGTT with adverse pregnancy outcomes among women with GDM compared to women without GDM; c: Associations of GWG categories after OGTT with adverse pregnancy outcomes among women with GDM compared to women without GDM Associations of GWG categories with adverse pregnancy outcomes among women with GDM compared to women without GDM. a: Associations of GWG categories at mid-late trimester with adverse pregnancy outcomes among women with GDM compared to women without GDM; b: Associations of GWG categories before OGTT with adverse pregnancy outcomes among women with GDM compared to women without GDM; c: Associations of GWG categories after OGTT with adverse pregnancy outcomes among women with GDM compared to women without GDM Sensitivity analysis After adjusting for MAP in late trimester (N = 12708), the associations between GWG rate and categories and adverse pregnancy outcomes remained consistent with the main findings (Additional file 1: Tables S3–S5). Discussion This study found that women with GDM exhibited distinct patterns of GWG compared with those without GDM, particularly during the period after OGTT, when GWG was significantly lower among women with GDM. Moreover, the associations between GWG and pregnancy outcomes varied between the two groups across specific gestational periods. Among women with GDM, IGWG at various stages was not significantly associated with adverse outcomes such as SGA, in contrast to the significant associations observed in women without GDM. Additionally, total GWG and GWG after OGTT were more strongly associated with an increased risk of LGA in the GDM group than in the non-GDM group. These findings improve our understanding of GWG patterns in women with GDM and emphasize the OGTT as a critical time point influencing subsequent GWG and pregnancy outcomes. Overall, these findings indicate that GDM alters the relationship between GWG and adverse pregnancy outcomes, revealing the inadequacy of existing guidelines and emphasizing the necessity for individualized weight management strategies after OGTT among women with GDM. As GWG management represents one of the most effective interventions for individuals diagnosed with GDM, the presence of GDM inevitably influences the progression of GWG. A previous prospective study has underscored the crucial role of GDM status as the sole independent predictor of GWG after recruitment of participants [15]. Therefore, our study strategically focuses on the timepoint of OGTT to divide GWG into two periods. This approach carries significant implications for guiding clinical practices and interventions, as typical weight management interventions often occur only after GDM diagnosis. We observed that women without GDM gained more weight both before and after OGTT compared to women with GDM. Moreover, after OGTT, women with GDM tended to transition to IGWG, while the opposite trend was observed in women without GDM. This observation is consistent with previous studies, which reported different patterns of GWG progression between the two groups [9, 15]. This pattern suggests that distinct factors influence GWG at different stages. The lower GWG in the GDM group prior to OGTT is likely attributable to their higher pre-pregnancy BMI, a well-established risk factor that also corresponds to a lower recommended GWG target. In contrast, the marked shift toward IGWG after OGTT indicates an additional, independent effect of the GDM diagnosis itself, as well as the subsequent implementation of medical nutrition therapy (MNT). Excessive GWG both before and after OGTT correlated significantly with LGA and macrosomia in both women with and without GDM, aligning with a recent meta-analysis [8]. These results suggested that avoiding EGWG during pregnancy could be helpful in the prevention of these adverse pregnancy outcomes. However, a retrospective cohort study involving 142 Israeli women demonstrated that EGWG was not associated with adverse pregnancy outcomes in diet-treated GDM pregnancies with adequate glycemic control [23]. This discrepancy could be explained by the differences between sample sizes, ethnicity and definition of adequate glycemic control among studies. Consistent with previous studies [18, 24], our study highlights disparities in the association of GWG with pregnancy outcomes between women with and without GDM. However, the mechanisms underlying these observations remain unclear. This difference may be attributed to the unique pathophysiological mechanisms associated with GDM. Previous studies have shown that, in the context of maternal diabetes, placental transport of energy substrates, such as glucose, lipids, and amino acids, is enhanced due to altered expression of relevant transport proteins. Notably, this process may not be fully reversed by diabetes treatment [25]. In addition, when diabetes is diagnosed at or after 24–28 weeks of gestation, pancreatic islet hyperplasia in the fetus may have already occurred, with abnormal insulin secretion persisting throughout the remainder of the pregnancy [26]. As a result, the fetus may exhibit an exaggerated insulin response to any glucose load or other insulin-stimulating substances, such as amino acids and fatty acids, ultimately leading to excessive fetal growth [26]. Moreover, EGWG during pregnancy also may alter the expression of genes involved in regulating placental nutrient transport [27]. Thus, in pregnancies with GDM, the abnormal intrauterine environment may exacerbate the impact of EGWG during pregnancy on fetal adiposity, which was demonstrated by a study [28]. These findings above indicate that the presence of GDM may amplify the impact of EGWG during pregnancy on fetal adiposity and neonatal fat accumulation. The results showed that compared to pregnant women without GDM, those with GDM who met the IOM GWG standards still had a higher risk of adverse outcomes, particularly after OGTT. This finding doesn’t imply that the association between GWG before OGTT in GDM women and pregnancy outcomes remained unchanged, as the intrauterine environment of women with GDM may undergo abnormal changes as early as mid-pregnancy. In fact, this suggests the need for personalized gestational weight management intervention for women with GDM, especially after OGTT, to improve their perinatal outcomes. Currently, although several studies have explored special GWG standards for women with GDM, most still rely on total GWG [29, 30]. However, in clinical practice, typical GWG management seems not to be done until the diagnosis, and medical staffs or pregnancies with GDM appear to be more concerned about GWG management after diagnosis. Similar with several studies [13, 14, 31], our study found that, in contrast with women without GDM, we did not observe increased risk of adverse outcomes among women with GDM who experienced with IGWG both before and after OGTT. Besides, a sub-analysis of prospective cohort study with 185 women with GDM indicated that women with IGWG occurred in late pregnancy would not develop adverse pregnancy outcomes and present with better metabolic profile postpartum [13]. These findings suggest that implementing stricter gestational weight gain recommendations, potentially below the IOM standards, after GDM diagnosis may be an effective approach to reducing adverse birth outcomes. In this study, we provided data of a large retrospective cohort with comprehensive clinical characteristics and a broad set of pregnancy outcomes. Standardized procedures were implemented throughout the study. In contrast with previous studies, GWG was divided by the time of OGTT instead of total GWG. This approach offers practicality and has more significant implications for guiding clinical practices. Additionally, this study simultaneously compared the effects of GWG between women with and without GDM to assess whether GDM modifies its association with pregnancy outcomes, addressing a gap in the current literature. However, this study has some limitations. Firstly, we used early pregnancy BMI instead of pre-pregnancy BMI due to practical reasons. Measuring pre-pregnancy weight in large population studies, particularly in low-risk women, is often unfeasible, and self-reported pre-pregnancy weight may introduce error or recall bias. In fact, pregnant women have 0–2 kg weight gain in the first trimester and weight of the first prenatal care in early pregnancy is usually used by obstetric clinicians as individual-specific baseline to monitor GWG, which may mean that our study has more practical application value [32]. Another limitation of our study is the absence of uterine artery measurements. We used MAP as a surrogate for maternal hemodynamics, which did not alter the results in sensitivity analyses, but it cannot fully reflect local uteroplacental blood flow. Future studies should include uterine artery assessments. Furthermore, this study lacked data on key aspects of GDM management, such as insulin treatment and medical nutrition therapy, as well as information on general maternal diet. In summary, this study revealed that women with GDM had distinct GWG patterns compared with those without GDM, especially after OGTT. Additionally, the associations between GWG and pregnancy outcomes differed by GDM status across specific gestational periods, indicating that GDM may modify these relationships. These findings highlight the importance of individualized weight management strategies following OGTT for women with GDM. However, the generalizability of these findings to other settings and populations requires further investigation in future research. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1